Fundraising Fox
Biomeme
Philadelphia, US · Founded 2012 · Delaware corporation · 64 employees on LinkedIn · 5 known investors
Find your way into Biomeme
Sign up to see every warm intro you have to Biomeme
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biomeme team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.
Founders & leadership
Biomeme was founded in 2012 by Max Perelman, Marc DeJong, Jesse vanWestrienen, Marc DeJohn, and Jesse van Westrienen.
Investors · 5
How we know: Darco Capital's portfolio page · Not right? Tell us
How we know: Future Communities Capital's portfolio page · Not right? Tell us
How we know: NextFab Ventures's portfolio page · Not right? Tell us
How we know: Robin Hood Ventures's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 2 rounds · 2014–2017
▶$4.5MraisedMay 2017 · 35 investors · Other Health CareRule 506(b)
- Max PerelmanExecutive Officer, Director
- Marc DeJongExecutive Officer, Director
- Jesse vanWestrienenExecutive Officer, Director
- Offering amount
- $5.2M
- Amount sold
- $4.5M
- Minimum investment
- $10K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$992.8KraisedJan 2014 · 19 investors · Other Health CareRule 506(c)
- Marc DeJohnExecutive Officer, Director
- Max PerelmanExecutive Officer, Director
- Jesse van WestrienenExecutive Officer, Director
- Offering amount
- $1.9M
- Amount sold
- $992.8K
- Minimum investment
- $10K
- Sales commissions
- $17.5K
- Placement agents
- Microventure Marketplace Inc.
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Biomeme.
In the news
Frequently asked questions
- What does Biomeme do?
- Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.
- Who founded Biomeme?
- Biomeme was founded by Max Perelman, Marc DeJong, Jesse vanWestrienen, Marc DeJohn, Jesse van Westrienen in 2012.
- Who are Biomeme's investors?
- Biomeme's investors include Darco Capital, Future Communities Capital, NextFab Ventures, Robin Hood Ventures, MicroVentures.
- How much funding has Biomeme raised?
- Biomeme has disclosed $5.5M raised across 2 rounds.
- Where is Biomeme headquartered?
- Biomeme is headquartered in Philadelphia, US.